14 Stocks Jim Cramer Discussed Including His 2 Top Quantum Computing Stocks

Page 7 of 13

7. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders In Q2 2025: 83

Pfizer Inc. (NYSE:PFE)’s shares are down by 10% year-to-date. In this appearance, Cramer discussed the firm’s $43 billion acquisition of drug company Seagen. Cramer has commented on the acquisition several times in 2025. For instance, in January, he stated that Pfizer Inc. (NYSE:PFE) had yet to launch any breakout drugs that would justify the deal. However, in March, Cramer was optimistic about the acquisition as he expected the deal to be “great.” This time, he commented on the overall sentiment surrounding Pfizer Inc. (NYSE:PFE):

“Pfizer is being viewed as a company that doesn’t really have anything. Meaning that people feel that the Seagen acquisition didn’t pay off. That was a very big acquisition. I don’t wanna write them off, but it’s kind of like cholesterol. . .where you finally just, you know you got a number of players in it, and everybody did well. I think that can happen here.”

Pfizer Inc. (NYSE:PFE) announced in September that it would showcase its cancer drug portfolio at an oncology conference due to be held in Berlin, Germany, next month. This portfolio includes phase three results of its bladder and prostate cancer drugs and phase two results of its small cell lung cancer treatment.

Page 7 of 13